Robert W. Ross, Chief Medical Officer at Surface Oncology, Inc. (SURF), sold 4,000 shares at $10.05 ($40K) on 2020-10-14, disclosed to the SEC on 2020-10-16.
Scheduled sale ($40k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SURF | SELL | 2022-01-14 | $204K | — | Filing → |
| SURF | SELL | 2021-02-18 | $11K | — | Filing → |
| SURF | SELL | 2021-01-15 | $108K | — | Filing → |